Press release

DSM reports very strong Q1 2011 continuing its positive momentum

Heerlen, NL, 27 Apr 2011 07:15 CEST

  • Q1 EBITDA from continuing operations up 14% to €325 million.
  • Life Sciences results driven by ongoing good performance in Nutrition.
  • Materials Sciences posts solid results reflecting volume gains and pricing strength.
  • EPS €0.91, 30% higher also due to a lower tax rate.
  • Martek integration underway; EBITDA in line with expectations.
  • 2011 is expected to be a strong year for DSM towards achieving the 2013 targets.

Commenting on the results, Feike Sijbesma, CEO/Chairman of the DSM Managing Board, said: “Our robust performance in Q1 2011 represents further progress towards our 2013 targets as we continue to successfully execute our strategy. This improvement can be attributed to our focus on innovation, our global customer base, excellent market positions and presence in high growth economies.

In the quarter we successfully completed our acquisition of Martek, welcoming its employees to DSM. The integration of Martek started immediately and the contribution to our profit is in line with expectations. Our business outlook for the rest of the year is positive and we expect 2011 to be a strong year for DSM.”

Key figures

in € million Q1 2011 Q1 2010 +/-
Continuing operations      
Net sales 2,234 1,933 16%
Operating profit before depreciation & amortization (EBITDA) 325 284* 14%**
Nutrition 173 166  
Pharma 0 14  
Performance Materials 91 71  
Polymer Intermediates 99 50  
Innovation Center -13 -13  
Corporate activities -25 -4*  
Operating profit (EBIT) 231 182* 27%
Discontinued operations:      
Net sales 111 297  
Operating profit before depreciation & amortization (EBITDA) 23 51  
Operating profit (EBIT) 23 36  
Total DSM:      
Net sales 2,345 2,230 5%
Operating profit before depreciation & amortization (EBITDA) 348 335 4%
Net profit before exceptional items 172 144 19%
Net result from exceptional items -6 -14  
Net profit 166 130 28%
Net earnings per ordinary share in €:      
before exceptional items, continuing operations 0.91 0.70 30%
including exceptional items, total DSM 0.98 0.78 26%

* of which € 8 million IFRS pension adjustment
** 18% if € 8 million IFRS pension adjustment is excluded

You can find the press release in full, including financial statements, below.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420
media.contacts@dsm.com

Dave Huizing

Vice President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864

This site uses cookies to store information on your computer.

Learn more